The short answer
Panax ginseng’s glucose effects vary, and added hypoglycemia with insulin glargine has not been established.
What this answer covers
Asian Panax ginseng root and specific extracts; American ginseng is a different species. Exact insulin glargine single-insulin product scope.
- Supplement or preparation
- Panax ginseng
- Medication ingredient
- insulin glargine
Some findings were null or opposite
Acute Asian-ginseng studies did not improve overall glucose or insulin responses and found a higher pooled two-hour glucose measure. This challenges a uniform glucose-lowering assumption.
One extract improved HbA1c
A short vinegar-extracted-ginseng study reported improved HbA1c in drug-naive patients. It did not test insulin glargine or establish clinical hypoglycemia with it.
Species and product differences matter
The contrasting studies do not define a safe combination dose or establish that insulin creates a need for ginseng. Asian and American species and differently processed extracts cannot be assumed equivalent.
Monitor changes without assuming spacing
Discuss the exact product and amount with the diabetes team and follow your glucose-monitoring and low-glucose treatment plan. Do not adjust insulin yourself. No protective supplement interval is established. Lantus and Toujeo have different concentrations and switching instructions. Keep the prescribed product and schedule; do not switch doses on your own.
Evidence and practical considerations
Side effects & toxicity
Variable preparation-specific glucose findings without exact insulin glargine co-use do not establish clinical hypoglycemia.
- Exact scope
- Asian Panax ginseng root and specific extracts; American ginseng is a different species. Exact insulin glargine single-insulin product scope. with insulin glargine RxCUI274783 IN; single-insulin subcutaneous product, concentration and schedule specific.
- Medication form and route
- subcutaneous insulin glargine; oral supplement
What remains uncertain
- No exact event rate or arbitrary insulin change.
Factors that may matter: Product; Dose; Meals; Other diabetes treatment; Kidney and liver function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed LANTUS U-100
Hypoglycemia can be severe; meal, activity and glucose-active treatment changes can require increased monitoring and clinician review. No intravenous or pump use. Once daily at the same time each day. Product-specific switching instructions distinguish concentrations.
How this applies: Exact insulin glargine RxCUI274783 IN, single-insulin product scope. Combination products not assumed equivalent.
No exact supplement interaction rate. Long-acting insulin is not a rapid mealtime formulation; concentration and device matter.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed TOUJEO U-300
Hypoglycemia can be severe; meal, activity and glucose-active treatment changes can require increased monitoring and clinician review. No intravenous or pump use. Once daily at the same time each day. Product-specific switching instructions distinguish concentrations.
How this applies: Exact insulin glargine RxCUI274783 IN, single-insulin product scope. Combination products not assumed equivalent.
No exact supplement interaction rate. Long-acting insulin is not a rapid mealtime formulation; concentration and device matter.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Two groups of11healthy volunteers.
No significant overall glucose/insulin effect; pooled Asian-ginseng treatment had higher two-hour glucose than placebo.
How this applies: Indirect for exact insulin glargine; original study drug, preparation and endpoint retained.
Small healthy-participant Asian-ginseng studies, not insulin glargine co-use. American-ginseng findings cannot be transferred automatically.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 72drug-naive adults with type 2 diabetes.
Vinegar-extracted Panax ginseng improved HbA1c in a small trial, with no severe adverse events reported in the abstract.
How this applies: Indirect for exact insulin glargine; original study drug, preparation and endpoint retained.
Drug-naive patients; no insulin glargine exposure. Specialized extract does not represent all root products.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact basal-insulin article with independently inspected product labels and original endpoint limits. | |
| Research summary published |
Article revision: 91cf845cc7edc248
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.